Correlation Between Editas Medicine and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Editas Medicine and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Editas Medicine and Eli Lilly and, you can compare the effects of market volatilities on Editas Medicine and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and Eli Lilly.

Diversification Opportunities for Editas Medicine and Eli Lilly

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Editas and Eli is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Editas Medicine i.e., Editas Medicine and Eli Lilly go up and down completely randomly.

Pair Corralation between Editas Medicine and Eli Lilly

Given the investment horizon of 90 days Editas Medicine is expected to under-perform the Eli Lilly. In addition to that, Editas Medicine is 3.02 times more volatile than Eli Lilly and. It trades about -0.14 of its total potential returns per unit of risk. Eli Lilly and is currently generating about 0.14 per unit of volatility. If you would invest  72,595  in Eli Lilly and on November 18, 2024 and sell it today you would earn a total of  11,832  from holding Eli Lilly and or generate 16.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Editas Medicine  vs.  Eli Lilly and

 Performance 
       Timeline  
Editas Medicine 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Eli Lilly 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady essential indicators, Eli Lilly showed solid returns over the last few months and may actually be approaching a breakup point.

Editas Medicine and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Editas Medicine and Eli Lilly

The main advantage of trading using opposite Editas Medicine and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind Editas Medicine and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals